Expression and Evaluation of a Novel HAV-VP1 and HBS-Ag Fusion Protein for Potential Applications in Immunization and Diagnosis
Introduction: Hepatitis A virus (HAV) is a causative agent of acute hepatitis in humans, infecting more than one million individuals every year, including both symptomatic and asymptomatic infections. The currently available preventive vaccines for HAV are based on either wild-type or live-attenu...
Saved in:
| Main Authors: | Mina Hannan1, Leila Jabalameli1*, Mohammad Reza Aghasadeghi2*, Naser Harzandi1, Seyed Mehdi Sadat2 |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pasteur Institute of Iran
2023-09-01
|
| Series: | Journal of Medical Microbiology and Infectious Diseases |
| Subjects: | |
| Online Access: | https://jommid.pasteur.ac.ir/article-1-568-en.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity assessment of Hepatitis A-VP1 and Hepatitis B surface antigen (HBsAg) fusion protein: a novel bivalent vaccine candidate
by: Mina Hannan, et al.
Published: (2025-07-01) -
Correlation between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients
by: Pete Maria, et al.
Published: (2023-01-01) -
Predictive value of HBeAg titer dynamics for HBsAg clearance in pediatric chronic hepatitis B
by: Sukjin Hong, et al.
Published: (2025-04-01) -
Protracted HBsAg-aemia in a Patient with Acute Hepatitis B
by: K. R. Dudina, et al.
Published: (2018-11-01) -
Nucleos(t)ide analogs continuation is not associated with a lower risk of HBsAg seroreversion following PEG-IFN-induced HBsAg loss
by: Na Gao, et al.
Published: (2025-03-01)